Paper1600596
Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro.
Osann K and 2 others. Cancer Chemother Pharmacol, 1992. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro. Papers, record 1600596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1600596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclosporine | Major topic |
| Daunorubicin | Major topic |
| Leukemia-Lymphoma, Adult T-Cell | Major topic |
| Verapamil | Major topic |
| Vincristine | Major topic |
| Drug Resistance | |
| Drug Synergism | |
| Humans | |
| Kinetics | |
| Tumor Cells, Cultured |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 422420 | Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/422420 | PubMed |
| 2 | 2364376 | Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water-insoluble vitamins and drugs. | Cancer Res | 1990 | https://conductscience.org/library/papers/2364376 | PubMed |
| 3 | 3457021 | Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3457021 | PubMed |
| 4 | 1977512 | Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P-glycoprotein. | Cancer Lett | 1990 | https://conductscience.org/library/papers/1977512 | PubMed |
| 5 | 6182160 | Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6182160 | PubMed |
| 6 | 1998966 | Correspondence re: Xiu F. Hu et al., Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990. | Cancer Res | 1991 | https://conductscience.org/library/papers/1998966 | PubMed |
| 7 | 2334897 | Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. | Cancer Res | 1990 | https://conductscience.org/library/papers/2334897 | PubMed |
| 8 | 7214365 | Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. | Cancer Res | 1981 | https://conductscience.org/library/papers/7214365 | PubMed |
| 9 | 2388483 | Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay. | Leukemia | 1990 | https://conductscience.org/library/papers/2388483 | PubMed |
| 10 | 3455667 | Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3455667 | PubMed |
| 11 | 528263 | Terminology in the description of drug-radiation interactions. | Int J Radiat Oncol Biol Phys | 1979 | https://conductscience.org/library/papers/528263 | PubMed |
| 12 | 2390489 | Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2390489 | PubMed |
| 13 | 2118896 | Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells. | Jpn J Cancer Res | 1990 | https://conductscience.org/library/papers/2118896 | PubMed |
| 14 | 2032209 | Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms. | Cancer Lett | 1991 | https://conductscience.org/library/papers/2032209 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9657975 | Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. | Biochem J | 1998 | https://conductscience.org/library/papers/9657975 | PubMed |
| 9547669 | Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study. | Invest New Drugs | 1997 | https://conductscience.org/library/papers/9547669 | PubMed |
| 8281626 | Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8281626 | PubMed |
| 7987977 | Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revertants of multidrug resistance. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/7987977 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1600596
GET https://conductscience.org/api/papers/v1/1600596/authors